Back to Results
First PageMeta Content
Research / Pharmaceutics / Pharmaceutical sciences / Clinical research / European Medicines Agency / Pharmaceutical industry


HMA Procedures and Governance (former Best Practice Guide) Status: VersionRevision: April 2015
Add to Reading List

Document Date: 2015-04-22 07:43:57


Open Document

File Size: 830,35 KB

Share Result on Facebook

City

Vilnius / Lisboa / FIMEA / /

Company

Medicines Agencies Management Group / EU National Competent Authorities / HMA Telematics Support Group / Healthcare / HMA European Surveillance Strategy Working Group / HMA-MG / Macolić Šarinić Croatian Agency for Medicinal Products / HMA Homeopathic Medicinal Products Working Group / HMA European Risk Management Strategy Facilitation Group / European Medicines Agencies Steering Group / MANDATE HMA Management Group / HMA Clinical Trial Facilitation Group / /

Country

Hungary / Estonia / Bulgaria / Cyprus / Latvia / Norway / Brazil / Portugal / Slovakia / Liechtenstein / Malta / Lithuania / Denmark / Germany / Romania / Croatia / Italy / Poland / Belgium / Luxembourg / Spain / Greece / Ireland / /

/

/

Organization

Sundhedsstyrelsen/Danish Health and Medicines Authority / Federal Agency for Medicines and Healthcare Products / Pharmacovigilance Working Party / Medicines Agencies Permanent Secretariat / PS / B-Vice_president National Organization for Medicines / Medicines and Healthcare products Regulatory Agency MHRA / A-Vice-President National Organization for Medicines / Office for Training / Xavier De Cuyper Federal Agency for Medicines and Healthcare Products / office for Registration of Medicinal / European Commission / European Union / Ministry of Health / Anthony Serracino-Inglott Medicines Authority / Viola Macolić Šarinić Croatian Agency for Medicinal Products and Medical Devices Ksaverska / HMA Task Force for Improvement of the Veterinary Legislation / HMA PS / European Medicines Agency / Bulgarian Drug Agency / Kristin Raudsepp Ravimiamet/State Agency of Medicines / Klaus Cichutek Paul-Ehrlich-Institut Paul-Ehrlich Straße / National Drug and Health Products Safety Agency / /

Person

Anne-Marie Vangsted / Ivana Šipić / Jakob Cold / Agence / Inguna Adoviča Zāļu / Xavier De Cuyper / Runa Hauksdóttir Hvannberg Lyfjastofnun / Pat O'Mahony / Axel Heides Gade / Zdeněk Blahuta Státní ústav / Giannis Karafyllis / Marius Savu Agentia Nationala / Jan Mazag Štátny ústav / Katarina Štraus / Paul-Ehrlich Straße / Katerina Fameli / Vivienne Saville / Assena Stoimenova Bulgarian / Victor Horta / Grzegorz Cessak Urzad Rejestracji Produktów / Karl Broich Bundesinstitut für Arzneimittel / Peter Gstöhl / Kristin Raudsepp Ravimiamet / Klaus Cichutek / Anthony Serracino-Inglott / Hilda Koszeginé Szalai Országos Gyógyszer / Statens Legemiddelverk Sven Oftedals / Jacqueline Genoux / Belén Crespo Sánchez-Eznarriaga Agencia / Brigitte Batliner / Christa Wirthumer-Hoche / Anatole France Saint-Denis / Luca Pani Agenzia Italiana del / David Obranovič / /

/

Position

Members MS E-mail address Phone number Chair / General / acting director / gov. it Belgium / gov. uk 0044 1932 338 301 Central Contact Point DE / responsible website editor / Director for DHMA / Dominique Martin Director General / Acting Director General / Governor / director / gov. uk info@mhra.gsi.gov.uk / chair / Audun Hågå Director General / Director for DHMA´s supervision / /

Product

ES / /

Technology

pdf / /

SocialTag